BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today that EKOS and their Netherlands distributor, AngioCare BV, are supporting a Dutch multicentre randomized trial (DUET) designed to ...
BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today the EKOS EkoSonic ® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The ...
Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions EKOS Corporation, a privately ...
Please provide your email address to receive an email when new articles are posted on . Catheter-directed thrombolysis was linked to less major bleeding than mechanical thrombectomy in patients with ...
Please provide your email address to receive an email when new articles are posted on . Patients with chronic deep vein thrombosis and postthrombotic syndrome can be treated safely and effectively ...
Adding intravascular ultrasound energy does not improve the efficacy of catheter-directed thrombolysis therapy in patients with acute iliofemoral deep vein thrombosis (DVT), according to a randomized ...
In essence, all of these devices are used to decrease the time taken for thrombus removal and possibly to reduce the risk of prolonged infusion (Box 1). Percutaneous mechanical thrombectomy (PMT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback